Skip to main content
. 2021 Apr 28;22(9):4687. doi: 10.3390/ijms22094687

Table 4.

List of altered metabolite levels identified in plasma/serum samples of BC patients to study several aspects of this pathology.

Metabolite BC vs. CTR ER+ vs. ER− MBC vs. EBC REL vs. NR Response to Chemotherapy
PR vs. GR Changes during Treatment
[115] [98] [95] [94] [111] [100] [99] [97] [98] [105] [108] [110] [113] [105] [102] [112] [106] [92] (NAC) [114] (NAC) [99] (NAC) [92] (NAC) [92] (NAC + Bevacizumab) [107] (Trastuzumab+ Everolimus)
3-hydroxy-2-Methyl-butanoic acid
3-Hydroxybutyrate
Acetate ↓↑↑
Acetoacetate ↓↑↓
Acetone
Alanine
Albumin Lysyl
Apo-B
Arginine
Betaine
Cholesterol
Choline
Citrate ↓↓↓
Creatine ↓↑↑
Creatinine ↓↑↑
Dimethylglutarate ↑↓↑
Ethanol
Formate ↓↓↓
Glucose
Glutamate
Glutamine
Glycerol
Glycerol-derived compounds
Glycerophosphocholine
Glycine ↑↑↓
Glycoproteins
Histidine ↓↑↑
Isoleucine ↑↓↓
Lactate ↑↓↓
Leucine ↑↓↑
Linolenic acid
Lipids
Lipoproteins
Lysine ↑↓↑
Mannose
Methanol
Methionine ↓↑↑
Myo-Inositol
N-acetyl glycoproteins
N-Acetyl-Cysteine
N-Acetyl-Glycine
Nonanedioic acid
Ornitine ↓↑↑
Phenylalanine ↓↑↑
Phospholipids
Proline
Pyruvate ↓↓↑
Threonine
Triglycerides
Tyrosine
Unsaturated lipids
Valine ↓↑↑

BC: breast cancer; CTR: control; ER: estrogen receptor; PR: poor responders; GR: good responders; NAC: neoadjuvant chemotherapy; MBC: metastatic BC; EBC: early BC; REL: relapse; NR: no relapse. ↑/↓ higher/lower level in the first group of each comparison.